Clinical trial
What is the Outcome of Treatment of Urinary Tract Infections Caused by Bacteria Producing Extended Spectrum Betalactamase in a Primary Care Setting?
NCT01531023 is registered in ClinicalTrials.gov with University of Oslo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- What is the Outcome of Treatment of Urinary Tract Infections Caused by Bacteria Producing Extended Spectrum Betalactamase in a Primary Care Setting?
- Lead sponsor
- University of Oslo
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2013
- Completion date
- September 30, 2016
- Enrollment
- 168 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.